Symphony Asset Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-1,095
| Closed | -$489K | – | 372 |
|
|
2017
Q3 | $489K | Sell |
1,095
-8
| -0.7% | -$3.57K | 0.05% | 264 |
|
|
2017
Q2 | $542K | Sell |
1,103
-54
| -5% | -$26.5K | 0.06% | 261 |
|
|
2017
Q1 | $448K | Sell |
1,157
-40
| -3% | -$15.5K | 0.04% | 299 |
|
|
2016
Q4 | $440K | Sell |
1,197
-43
| -3% | -$15.8K | 0.04% | 305 |
|
|
2016
Q3 | $498K | Sell |
1,240
-66
| -5% | -$26.5K | 0.05% | 266 |
|
|
2016
Q2 | $457K | Sell |
1,306
-67
| -5% | -$23.4K | 0.05% | 241 |
|
|
2016
Q1 | $495K | Sell |
1,373
-37
| -3% | -$13.3K | 0.05% | 250 |
|
|
2015
Q4 | $766K | Sell |
1,410
-47
| -3% | -$25.5K | 0.08% | 220 |
|
|
2015
Q3 | $677K | Sell |
1,457
-44
| -3% | -$20.4K | 0.08% | 255 |
|
|
2015
Q2 | $766K | Buy |
1,501
+50
| +3% | +$25.5K | 0.1% | 216 |
|
|
2015
Q1 | $655K | Buy |
+1,451
| New | +$655K | 0.08% | 260 |
|